Literature DB >> 32259163

Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.

Ilaha Isali1, Mohammed Adel Ali Al-Sadawi1, Arshna Qureshi2, Ahmad O Khalifa1,3, Mukesh K Agrawal4, Sanjeev Shukla1.   

Abstract

Growth factors play active role in cells proliferation, embryonic development regulation and cellular differentiation. Altered level growth factors promote malignant transformation of normal cells. There has been significant progress made in form of drugs, inhibitors and monoclonal antibodies against altered growth factor to treat the malignant form of cancer. Moreover, these altered growth factors in prostate cancer increases steroidal hormone levels, which promotes progression. Though this review we are highlighting the majorly involved growth factors in prostate carcinogenesis, this will enable to better design the therapeutic strategies to inhibit prostate cancer progression.

Entities:  

Year:  2019        PMID： 32259163      PMCID： PMC7133721     

Source DB:  PubMed          Journal:  Int J Cell Biol Physiol


  108 in total

1.  IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction.

Authors:  Chong Chen; Qiuyang Zhang; Sen Liu; Keshab R Parajuli; Yine Qu; Jiandong Mei; Zhiquan Chen; Hui Zhang; Damir B Khismatullin; Zongbing You
Journal:  Prostate       Date:  2015-02-14       Impact factor: 4.104

2.  Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.

Authors:  Giles O Hellawell; Gareth D H Turner; David R Davies; Richard Poulsom; Simon F Brewster; Valentine M Macaulay
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

3.  Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin.

Authors:  K A Olson; H R Byers; M E Key; J W Fett
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

4.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.

Authors:  Jennifer M McCoy; Joan R Wicks; Laurent P Audoly
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

5.  Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.

Authors:  Sun Jin Kim; Hisanori Uehara; Sertac Yazici; Robert R Langley; Junqin He; Rachel Tsan; Dominic Fan; Jerald J Killion; Isaiah J Fidler
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

6.  Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.

Authors:  Shahrokh F Shariat; Michael W Kattan; Erica Traxel; Ben Andrews; Kuichun Zhu; Thomas M Wheeler; Kevin M Slawin
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

7.  Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.

Authors:  Nathaniel Polnaszek; Bernard Kwabi-Addo; Leif E Peterson; Mustafa Ozen; Norman M Greenberg; Sagrario Ortega; Claudio Basilico; Michael Ittmann
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

8.  Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.

Authors:  Charles J Ryan; Christopher M Haqq; Jeffrey Simko; Daisuke F Nonaka; June M Chan; Vivian Weinberg; Eric J Small; Ira D Goldfine
Journal:  Urol Oncol       Date:  2007 Mar-Apr       Impact factor: 3.498

9.  MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.

Authors:  Lin Wang; Guanhua Song; Weiwei Tan; Mei Qi; Lili Zhang; Jonathan Chan; Jindan Yu; Jinxiang Han; Bo Han
Journal:  Oncotarget       Date:  2015-11-03

10.  Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest.

Authors:  Christine Oak; Ahmad O Khalifa; Ilaha Isali; Natarajan Bhaskaran; Ethan Walker; Sanjeev Shukla
Journal:  Int J Oncol       Date:  2018-05-16       Impact factor: 5.650
View more
  1 in total

1.  Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells.

Authors:  Md Hafiz Uddin; Yiwei Li; Husain Yar Khan; Irfana Muqbil; Amro Aboukameel; Rachel E Sexton; Shriya Reddy; Yosef Landesman; Trinayan Kashyap; Asfar S Azmi; Elisabeth I Heath
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.